Coral

Coral is a precision medicine company that leverages human genetic variation to predict drug response and develop targeted therapies. The company's proprietary platform combines large-scale genomic data with functional cellular assays to understand how different genetic backgrounds influence the efficacy and safety of medications. By focusing on complex autoimmune conditions such as Inflammatory Bowel Disease (IBD), Coral aims to replace the current trial-and-error approach to treatment with data-driven, personalized medicine. The company partners with major pharmaceutical firms to optimize clinical trials and is building an internal pipeline of precision-targeted assets.